Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ALDOA |
| Upstream (Parents) |
|---|
| (<<) PKM2 → ALDOA |
| (<<) MAFF → ALDOA |
| (<<) C1RL → ALDOA |
| Downstream (Children) |
|---|
| ALDOA → TSPAN15 (>>) |
| ALDOA → CLIP2 (>>) |
| ALDOA → TNIP2 (>>) |
| ALDOA → SEC61A2 (>>) |
| ALDOA → LRRC6 (>>) |
| ALDOA → BOLA2B///BOLA2 (>>) |
| ALDOA → MTMR2 (>>) |
| ALDOA → MMP12 (>>) |
| ALDOA → PTPRR (>>) |
| ALDOA → CA12 (>>) |
| ALDOA → SLC6A8 (>>) |
| ALDOA → SLC2A1 (>>) |
| ALDOA → SRCAP (>>) |
| ALDOA → ENO2 (>>) |
| ALDOA → RPS14 (>>) |
| ALDOA → LOC653562///SLC6A10P///SLC6A8 (>>) |
| ALDOA → HOXB6 (>>) |
| ALDOA → PGP (>>) |
| ALDOA → PKM2 (>>) |
| ALDOA → SPP1 (>>) |
| ALDOA → EGLN3 (>>) |
| ALDOA → PFKP (>>) |
| ALDOA → HK2 (>>) |
| ALDOA → RNF24 (>>) |
| ALDOA → FAM184A (>>) |
| ALDOA → ITM2C (>>) |
| ALDOA → INPP4B (>>) |
| ALDOA → NDRG1 (>>) |
| ALDOA → SPAG4 (>>) |
| ALDOA → TES (>>) |
| ALDOA → EPB41L2 (>>) |
| ALDOA → DDIT4 (>>) |
| ALDOA → TPI1 (>>) |
| ALDOA → DLGAP4 (>>) |
| ALDOA → MEIS3P1 (>>) |
| ALDOA → SYK (>>) |
| ALDOA → KHDC1///SPA17 (>>) |
| ALDOA → KIAA1609 (>>) |
| ALDOA → P4HA2 (>>) |
| ALDOA → SDPR (>>) |
| ALDOA → SLC10A3 (>>) |
| ALDOA → KDM3A (>>) |
